Research ArticleConference Proceedings

The Functional and Psychosocial Consequences of COPD

Anne M Mathews
Respiratory Care July 2023, 68 (7) 914-926; DOI: https://doi.org/10.4187/respcare.10542

REFERENCES

  1. 1.↵
    1. Safiri S,
    2. Carson-Chahhoud K,
    3. Noori M,
    4. Nejadghaderi SA,
    5. Sullman MJM,
    6. Ahmadian Heris J,
    7. et al
    . Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. BMJ 2022;378:e069679.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Negewo NA,
    2. Gibson PG,
    3. McDonald VM
    . COPD and its comorbidities: impact, measurement and mechanisms. Respirology 2015;20(8):1160-1171.
    OpenUrlPubMed
  3. 3.↵
    1. Fabbri LM,
    2. Rabe KF
    . From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797-799.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Vanfleteren LEGW,
    2. Spruit MA,
    3. Groenen M,
    4. Gaffron S,
    5. van Empel VPM,
    6. Bruijnzeel PLB,
    7. et al
    . Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(7):728-735.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Putcha N,
    2. Drummond MB,
    3. Wise RA,
    4. Hansel NN
    . Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med 2015;36(4):575-591.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Agusti A,
    2. Calverley PMA,
    3. Celli B,
    4. Coxson HO,
    5. Edwards LD,
    6. Lomas DA,
    7. et al
    ; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11(1):122.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Decramer M,
    2. Janssens W
    . Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013;1(1):73-83.
    OpenUrl
  8. 8.↵
    1. van Manen JG,
    2. Bindels PJ,
    3. Dekker EW,
    4. Ijzermans CJ,
    5. Bottema BJ,
    6. van der Zee JS,
    7. Schadé E
    . Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med 2001;95(6):496-504.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Putcha N,
    2. Puhan MA,
    3. Hansel NN,
    4. Drummond MB,
    5. Boyd CM
    . Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001–2008. COPD 2013;10(3):324-332.
    OpenUrlCrossRefWeb of Science
  10. 10.↵
    1. Soler-Cataluña JJ,
    2. Martínez-García MA,
    3. Román Sánchez P,
    4. Salcedo E,
    5. Navarro M,
    6. Ochando R
    . Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60(11):925-931.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Roberts CM,
    2. Stone RA,
    3. Lowe D,
    4. Pursey NA,
    5. Buckingham RJ
    . Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD 2011;8(5):354-361.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Menzin J,
    2. Boulanger L,
    3. Marton J,
    4. Guadagno L,
    5. Dastani H,
    6. Dirani R,
    7. et al
    . The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med 2008;102(9):1248-1256.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Cavaillès A,
    2. Brinchault-Rabin G,
    3. Dixmier A,
    4. Goupil F,
    5. Gut-Gobert C,
    6. Marchand-Adam S,
    7. et al
    . Comorbidities of COPD. Eur Respir Rev 2013;22(130):454-475.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Smith MC,
    2. Wrobel JP
    . Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:871-888.
    OpenUrlPubMed
  15. 15.↵
    1. Pelgrim CE,
    2. Peterson JD,
    3. Gosker HR,
    4. Schols AMWJ,
    5. van Helvoort A,
    6. Garssen J,
    7. et al
    . Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both? Eur J Pharmacol 2019;842:99-110.
    OpenUrlPubMed
  16. 16.↵
    1. Divo M,
    2. Cote C,
    3. de Torres JP,
    4. Casanova C,
    5. Marin JM,
    6. Pinto-Plata V,
    7. et al
    ; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186(2):155-161.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Yohannes AM,
    2. Willgoss TG,
    3. Baldwin RC,
    4. Connolly MJ
    . Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 2010;25(12):1209-1221.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Vögele C,
    2. von Leupoldt A
    . Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med 2008;102(5):764-773.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Kunik ME,
    2. Roundy K,
    3. Veazey C,
    4. Souchek J,
    5. Richardson P,
    6. Wray NP,
    7. Stanley MA
    . Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005;127(4):1205-1211.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Kunik ME,
    2. Veazey C,
    3. Cully JA,
    4. Souchek J,
    5. Graham DP,
    6. Hopko D,
    7. et al
    . COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008;38(3):385-396.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    1. Kühl K,
    2. Schürmann W,
    3. Rief W
    . Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis 2008;3(4):727-736.
    OpenUrlPubMed
  22. 22.↵
    1. Gudmundsson G,
    2. Gislason T,
    3. Janson C,
    4. Lindberg E,
    5. Hallin R,
    6. Ulrik CS,
    7. et al
    . Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005;26(3):414-419.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Gudmundsson G,
    2. Gislason T,
    3. Janson C,
    4. Lindberg E,
    5. Suppli Ulrik C,
    6. Brøndum E,
    7. et al
    . Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006;100(1):87-93.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Zhang MWB,
    2. Ho RCM,
    3. Cheung MWL,
    4. Fu E,
    5. Mak A
    . Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011;33(3):217-223.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Livermore N,
    2. Sharpe L,
    3. McKenzie D
    . Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respir Med 2010;104(9):1246-1253.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Tyrer P
    . The case for cothymia: mixed anxiety and depression as a single diagnosis. Br J Psychiatry 2001;179:191-193.
    OpenUrlFREE Full Text
  27. 27.↵
    1. Di Marco F,
    2. Verga M,
    3. Reggente M,
    4. Maria Casanova F,
    5. Santus P,
    6. Blasi F,
    7. et al
    . Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100(10):1767-1774.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Laurin C,
    2. Lavoie KL,
    3. Bacon SL,
    4. Dupuis G,
    5. Lacoste G,
    6. Cartier A,
    7. Labrecque M
    . Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007;132(1):148-155.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Gut-Gobert C,
    2. Cavaillès A,
    3. Dixmier A,
    4. Guillot S,
    5. Jouneau S,
    6. Leroyer C,
    7. et al
    . Women and COPD: do we need more evidence? Eur Respir Rev 2019;28(151):180055.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Thun MJ,
    2. Carter BD,
    3. Feskanich D,
    4. Freedman ND,
    5. Prentice R,
    6. Lopez AD,
    7. et al
    . 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368(4):351-364.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Ancochea J,
    2. Miravitlles M,
    3. García-Río F,
    4. Muñoz L,
    5. Sánchez G,
    6. Sobradillo V,
    7. et al
    . Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol 2013;49(6):223-229.
    OpenUrlPubMed
  32. 32.↵
    1. Watson L,
    2. Vestbo J,
    3. Postma DS,
    4. Decramer M,
    5. Rennard S,
    6. Kiri VA,
    7. et al
    . Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004;98(12):1207-1213.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Martinez FJ,
    2. Curtis JL,
    3. Sciurba F,
    4. Mumford J,
    5. Giardino ND,
    6. Weinmann G,
    7. et al
    ; National Emphysema Treatment Trial Research Group. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176(3):243-252.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. de Torres JP,
    2. Casanova C,
    3. Hernández C,
    4. Abreu J,
    5. Aguirre-Jaime A,
    6. Celli BR
    . Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128(4):2012-2016.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Sverzellati N,
    2. Calabrò E,
    3. Randi G,
    4. La Vecchia C,
    5. Marchianò A,
    6. Kuhnigk J-M,
    7. et al
    . Sex differences in emphysema phenotype in smokers without airflow obstruction. Eur Respir J 2009;33(6):1320-1328.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Grydeland TB,
    2. Dirksen A,
    3. Coxson HO,
    4. Pillai SG,
    5. Sharma S,
    6. Eide GE,
    7. et al
    . Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 2009;34(4):858-865.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Foreman MG,
    2. Zhang L,
    3. Murphy J,
    4. Hansel NN,
    5. Make B,
    6. Hokanson JE,
    7. et al
    ; COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011;184(4):414-420.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Silverman EK,
    2. Weiss ST,
    3. Drazen JM,
    4. Chapman HA,
    5. Carey V,
    6. Campbell EJ,
    7. et al
    . Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(6):2152-2158.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Raherison C,
    2. Tillie-Leblond I,
    3. Prudhomme A,
    4. Taillé C,
    5. Biron E,
    6. Nocent-Ejnaini C,
    7. et al
    . Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health 2014;14(1):31.
    OpenUrl
  40. 40.↵
    1. Gater R,
    2. Tomenson B,
    3. Percival C,
    4. Chaudhry N,
    5. Waheed W,
    6. Dunn G,
    7. et al
    . Persistent depressive disorders and social stress in people of Pakistani origin and white Europeans in UK. Soc Psychiatry Psychiatr Epidemiol 2009;44(3):198-207.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Weich S,
    2. Nazroo J,
    3. Sproston K,
    4. McManus S,
    5. Blanchard M,
    6. Erens B,
    7. et al
    . Common mental disorders and ethnicity in England: the EMPIRIC study. Psychol Med 2004;34(8):1543-1551.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Schane RE,
    2. Walter LC,
    3. Dinno A,
    4. Covinsky KE,
    5. Woodruff PG
    . Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 2008;23(11):1757-1762.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Maurer J,
    2. Rebbapragada V,
    3. Borson S,
    4. Goldstein R,
    5. Kunik ME,
    6. Yohannes AM,
    7. Hanania NA
    ; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008;134(4 Suppl):43S-56S.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Zareifopoulos N,
    2. Bellou A,
    3. Spiropoulou A,
    4. Spiropoulos K
    . Prevalence, contribution to disease burden and management of comorbid depression and anxiety in chronic obstructive pulmonary disease: a narrative review. COPD 2019;16(5-6):406-417.
    OpenUrl
  45. 45.↵
    1. Pumar MI,
    2. Gray CR,
    3. Walsh JR,
    4. Yang IA,
    5. Rolls TA,
    6. Ward DL
    . Anxiety and depression-important psychological comorbidities of COPD. J Thorac Dis 2014;6(11):1615-1631.
    OpenUrlPubMed
  46. 46.↵
    1. Schuler M,
    2. Wittmann M,
    3. Faller H,
    4. Schultz K
    . The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis. J Affect Disord 2018;240:33-40.
    OpenUrl
  47. 47.↵
    1. van den Bemt L,
    2. Schermer T,
    3. Bor H,
    4. Smink R,
    5. van Weel-Baumgarten E,
    6. Lucassen P,
    7. van Weel C
    . The risk for depression comorbidity in patients with COPD. Chest 2009;135(1):108-114.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Hanania NA,
    2. Müllerova H,
    3. Locantore NW,
    4. Vestbo J,
    5. Watkins ML,
    6. Wouters EF,
    7. et al
    ; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011;183(5):604-611.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Willgoss TG,
    2. Yohannes AM
    . Anxiety disorders in patients with COPD: a systematic review. Respir Care 2013;58(5):858-866.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Omachi TA,
    2. Blanc PD,
    3. Claman DM,
    4. Chen H,
    5. Yelin EH,
    6. Julian L,
    7. Katz PP
    . Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med 2012;13(5):476-483.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Peiffer G,
    2. Underner M,
    3. Perriot J,
    4. Fond G
    . COPD, anxiety-depression and cognitive disorders: does inflammation play a major role? Rev Mal Respir 2021;38(4):357-371.
    OpenUrl
  52. 52.↵
    1. Rybka J,
    2. Korte SM,
    3. Czajkowska-Malinowska M,
    4. Wiese M,
    5. Kędziora-Kornatowska K,
    6. Kędziora J
    . The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ. Clin Exp Med 2016;16(4):493-502.
    OpenUrl
  53. 53.↵
    1. Janssen DJ,
    2. Müllerova H,
    3. Agusti A,
    4. Yates JC,
    5. Tal-Singer R,
    6. Rennard SI,
    7. et al
    ; Eclipse Investigators. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med 2014;108(11):1647-1654.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Eagan TML,
    2. Ueland T,
    3. Wagner PD,
    4. Hardie JA,
    5. Mollnes TE,
    6. Damås JK,
    7. et al
    . Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 2010;35(3):540-548.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. van Dijk EJ,
    2. Vermeer SE,
    3. de Groot JC,
    4. van de Minkelis J,
    5. Prins ND,
    6. Oudkerk M,
    7. et al
    . Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004;75(5):733-736.
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Campbell J III.,
    2. Coffey CE
    . Neuropsychiatric significance of subcortical hyperintensity. J Neuropsychiatry Clin Neurosci 2001;13(2):261-288.
    OpenUrlPubMedWeb of Science
  57. 57.↵
    1. Atlantis E,
    2. Fahey P,
    3. Cochrane B,
    4. Smith S
    . Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 2013;144(3):766-777.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    1. Panagioti M,
    2. Scott C,
    3. Blakemore A,
    4. Coventry PA
    . Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:1289-1306.
    OpenUrlPubMed
  59. 59.↵
    1. Wagena EJ,
    2. Arrindell WA,
    3. Wouters EFM,
    4. van Schayck CP
    . Are patients with COPD psychologically distressed? Eur Respir J 2005;26(2):242-248.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Montserrat-Capdevila J,
    2. Godoy P,
    3. Marsal JR,
    4. Barbé F,
    5. Pifarré J,
    6. Alsedà M,
    7. Ortega M
    . Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease. Lung 2017;195(1):77-85.
    OpenUrlCrossRef
  61. 61.↵
    1. Larsen CH,
    2. Bendstrup E,
    3. Neergaard MA
    . Screening tools for depression and anxiety in patients with chronic obstructive pulmonary disease - a systematic review. COPD 2021;18(6):683-689.
    OpenUrl
  62. 62.↵
    1. Julian LJ,
    2. Gregorich SE,
    3. Earnest G,
    4. Eisner MD,
    5. Chen H,
    6. Blanc PD,
    7. et al
    . Screening for depression in chronic obstructive pulmonary disease. COPD 2009;6(6):452-458.
    OpenUrlCrossRef
  63. 63.↵
    1. Phan T,
    2. Carter O,
    3. Adams C,
    4. Waterer G,
    5. Chung LP,
    6. Hawkins M,
    7. et al
    . Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2016;13(3):220-228.
    OpenUrlCrossRefPubMed
  64. 64.↵
    1. Aydin IO,
    2. Uluşahin A
    . Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001;23(2):77-83.
    OpenUrlCrossRefPubMedWeb of Science
  65. 65.↵
    1. Stage KB,
    2. Middelboe T,
    3. Pisinger C
    . Measurement of depression in patients with chronic obstructive pulmonary disease (COPD). Nord J Psychiatry 2003;57(4):297-301.
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    1. Yohannes AM,
    2. Baldwin RC,
    3. Connolly MJ
    . Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriat Psychiatry 2000;15(12):1090-1096.
    OpenUrlCrossRefPubMedWeb of Science
  67. 67.↵
    1. Cheung G,
    2. Patrick C,
    3. Sullivan G,
    4. Cooray M,
    5. Chang CL
    . Sensitivity and specificity of the Geriatric Anxiety Inventory and the Hospital Anxiety and Depression Scale in the detection of anxiety disorders in older people with chronic obstructive pulmonary disease. Int Psychogeriatr 2012;24(1):128-136.
    OpenUrlCrossRefPubMed
  68. 68.↵
    1. Baker AM,
    2. Holbrook JT,
    3. Yohannes AM,
    4. Eakin MN,
    5. Sugar EA,
    6. Henderson RJ,
    7. et al
    ; American Lung Association Airways Clinical Research Centers. Test performance characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2018;15(8):926-934.
    OpenUrl
  69. 69.↵
    1. Zigmond AS,
    2. Snaith RP
    . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-370.
    OpenUrlCrossRefPubMedWeb of Science
  70. 70.↵
    1. Spitzer RL,
    2. Kroenke K,
    3. Williams JBW,
    4. Löwe B
    . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092-1097.
    OpenUrlCrossRefPubMedWeb of Science
  71. 71.↵
    1. Willgoss TG,
    2. Goldbart J,
    3. Fatoye F,
    4. Yohannes AM
    . The development and validation of the anxiety inventory for respiratory disease. Chest 2013;144(5):1587-1596.
    OpenUrl
  72. 72.↵
    1. Bakas T,
    2. McLennon SM,
    3. Carpenter JS,
    4. Buelow JM,
    5. Otte JL,
    6. Hanna KM,
    7. et al
    . Systematic review of health-related quality of life models. Health Qual Life Outcomes 2012;10:134.
    OpenUrlCrossRefPubMed
  73. 73.↵
    1. Ormel J,
    2. Kempen GI,
    3. Deeg DJ,
    4. Brilman EI,
    5. van Sonderen E,
    6. Relyveld J
    . Functioning, well-being, and health perception in late middle-aged and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc 1998;46(1):39-48.
    OpenUrlCrossRefPubMedWeb of Science
  74. 74.↵
    1. Wells KB,
    2. Golding JM,
    3. Burnam MA
    . Psychiatric disorder and limitations in physical functioning in a sample of the Los Angeles general population. Am J Psychiatry 1988;145(6):712-717.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    1. Yohannes AM,
    2. Chen W,
    3. Moga AM,
    4. Leroi I,
    5. Connolly MJ
    . Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc 2017;18(5):451.e1-451.e11.
    OpenUrlPubMed
  76. 76.↵
    1. Blakemore A,
    2. Dickens C,
    3. Guthrie E,
    4. Bower P,
    5. Kontopantelis E,
    6. Afzal C,
    7. Coventry PA
    . Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2014;9:501-512.
    OpenUrlPubMed
  77. 77.↵
    1. Omachi TA,
    2. Katz PP,
    3. Yelin EH,
    4. Gregorich SE,
    5. Iribarren C,
    6. Blanc PD,
    7. Eisner MD
    . Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009;122(8):778.e9-15-778.15.
    OpenUrl
  78. 78.↵
    1. Ng T-P,
    2. Niti M,
    3. Tan W-C,
    4. Cao Z,
    5. Ong K-C,
    6. Eng P
    . Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167(1):60-67.
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.↵
    1. Kim HF,
    2. Kunik ME,
    3. Molinari VA,
    4. Hillman SL,
    5. Lalani S,
    6. Orengo CA,
    7. et al
    . Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41(6):465-471.
    OpenUrlCrossRefPubMedWeb of Science
  80. 80.↵
    1. Tsiligianni I,
    2. Kocks J,
    3. Tzanakis N,
    4. Siafakas N,
    5. van der Molen T
    . Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J 2011;20(3):257-268.
    OpenUrlCrossRefPubMed
  81. 81.↵
    1. Doyle T,
    2. Palmer S,
    3. Johnson J,
    4. Babyak MA,
    5. Smith P,
    6. Mabe S,
    7. et al
    . Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int J Psychiatry Med 2013;45(2):189-202.
    OpenUrlCrossRefPubMed
  82. 82.↵
    1. Tselebis A,
    2. Bratis D,
    3. Kosmas E,
    4. Harikiopoulou M,
    5. Theodorakopoulou E,
    6. Dumitru S,
    7. et al
    . Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease. Ann Gen Psychiatry 2011;10:32.
    OpenUrlCrossRefPubMed
  83. 83.↵
    1. Balcells E,
    2. Gea J,
    3. Ferrer J,
    4. Serra I,
    5. Orozco-Levi M,
    6. de Batlle J,
    7. et al
    ; PAC-COPD Study Group. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 2010;8:108.
    OpenUrlCrossRefPubMed
  84. 84.↵
    1. Janssen DJA,
    2. Spruit MA,
    3. Schols JMGA,
    4. Cox B,
    5. Nawrot TS,
    6. Curtis JR,
    7. Wouters EFM
    . Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest 2012;141(5):1251-1259.
    OpenUrlCrossRefPubMedWeb of Science
  85. 85.↵
    1. Meier C,
    2. Bodenmann G,
    3. Mörgeli H,
    4. Jenewein J
    . Dyadic coping, quality of life, and psychological distress among chronic obstructive pulmonary disease patients and their partners. Int J Chron Obstruct Pulmon Dis 2011;6:583-596.
    OpenUrlPubMed
  86. 86.↵
    1. Laurin C,
    2. Moullec G,
    3. Bacon SL,
    4. Lavoie KL
    . Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012;185(9):918-923.
    OpenUrlCrossRefPubMedWeb of Science
  87. 87.↵
    1. Pooler A,
    2. Beech R
    . Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis 2014;9:315-330.
    OpenUrlPubMed
  88. 88.↵
    1. Volpato E,
    2. Toniolo S,
    3. Pagnini F,
    4. Banfi P
    . The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis 2021;16:2001-2021.
    OpenUrl
  89. 89.↵
    1. Regvat J,
    2. Žmitek A,
    3. Vegnuti M,
    4. Košnik M,
    5. Šuškovič S
    . Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res 2011;39(3):1028-1038.
    OpenUrlPubMed
  90. 90.↵
    1. DiMatteo MR,
    2. Lepper HS,
    3. Croghan TW
    . Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160(14):2101-2107.
    OpenUrlCrossRefPubMedWeb of Science
  91. 91.↵
    1. Hogea S-P,
    2. Tudorache E,
    3. Fildan AP,
    4. Fira-Mladinescu O,
    5. Marc M,
    6. Oancea C
    . Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J 2020;14(3):183-197.
    OpenUrl
  92. 92.↵
    1. Montserrat-Capdevila J,
    2. Godoy P,
    3. Marsal JR,
    4. Ortega M,
    5. Pifarré J,
    6. Alsedà M,
    7. et al
    . Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr Care 2018;54(3):398-404.
    OpenUrl
  93. 93.↵
    1. Esteban C,
    2. Quintana JM,
    3. Moraza J,
    4. Aburto M,
    5. Aguirre U,
    6. Aguirregomoscorta JI,
    7. et al
    . BODE-Index vs HADO-score in chronic obstructive pulmonary disease: which one to use in general practice? BMC Med 2010;8:28.
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. Fan VS,
    2. Ramsey SD,
    3. Giardino ND,
    4. Make BJ,
    5. Emery CF,
    6. Diaz PT,
    7. et al
    ; National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007;167(21):2345-2353.
    OpenUrlCrossRefPubMedWeb of Science
  95. 95.↵
    1. Groenewegen KH,
    2. Schols AMWJ,
    3. Wouters EFM
    . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124(2):459-467.
    OpenUrlCrossRefPubMedWeb of Science
  96. 96.↵
    1. Almagro P,
    2. Calbo E,
    3. Ochoa de Echagüen A,
    4. Barreiro B,
    5. Quintana S,
    6. Heredia JL,
    7. Garau J
    . Mortality after hospitalization for COPD. Chest 2002;121(5):1441-1448.
    OpenUrlCrossRefPubMedWeb of Science
  97. 97.↵
    1. de Voogd JN,
    2. Wempe JB,
    3. Koëter GH,
    4. Postema K,
    5. van Sonderen E,
    6. Ranchor AV,
    7. et al
    . Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009;135(3):619-625.
    OpenUrlCrossRefPubMedWeb of Science
  98. 98.↵
    1. Roche N
    . Where current pharmacological therapies fall short in COPD: symptom control is not enough. Eur Respir Rev 2007;16(105):98-104.
    OpenUrlAbstract/FREE Full Text
  99. 99.↵
    1. Prince M,
    2. Patel V,
    3. Saxena S,
    4. Maj M,
    5. Maselko J,
    6. Phillips MR,
    7. Rahman A
    . No health without mental health. Lancet 2007;370(9590):859-877.
    OpenUrlCrossRefPubMedWeb of Science
  100. 100.↵
    1. Coventry PA,
    2. Bower P,
    3. Keyworth C,
    4. Kenning C,
    5. Knopp J,
    6. Garrett C,
    7. et al
    . The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One 2013;8(4):e60532.
    OpenUrlCrossRefPubMed
  101. 101.↵
    1. Greenberger D,
    2. Padesky CA
    . Mind over mood: A cognitive therapy treatment manual for clients. Guilford Press, New York, NY; 1995.
  102. 102.↵
    1. Cafarella PA,
    2. Effing TW,
    3. Usmani Z-A,
    4. Frith PA
    . Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology 2012;17(4):627-638.
    OpenUrlCrossRefPubMedWeb of Science
  103. 103.↵
    1. Tyrer P,
    2. Cooper S,
    3. Salkovskis P,
    4. Tyrer H,
    5. Crawford M,
    6. Byford S,
    7. et al
    . Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet 2014;383(9913):219-225.
    OpenUrlCrossRefPubMedWeb of Science
  104. 104.↵
    1. Moayeri F,
    2. Dunt D,
    3. Hsueh Y-SA,
    4. Doyle C
    . Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. Expert Rev Pharmacoecon Outcomes Res 2019;19(3):331-340.
    OpenUrl
  105. 105.↵
    1. Williams MT,
    2. Johnston KN,
    3. Paquet C
    . Cognitive behavioral therapy for people with chronic obstructive pulmonary disease: rapid review. Int J Chron Obstruct Pulmon Dis 2020;15:903-919.
    OpenUrlPubMed
  106. 106.↵
    1. Pumar MI,
    2. Roll M,
    3. Fung P,
    4. Rolls TA,
    5. Walsh JR,
    6. Bowman RV,
    7. et al
    . Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. J Thorac Dis 2019;11(Suppl 17):S2238-S2253.
    OpenUrl
  107. 107.↵
    1. Kunik ME,
    2. Braun U,
    3. Stanley MA,
    4. Wristers K,
    5. Molinari V,
    6. Stoebner D,
    7. Orengo CA
    . One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001;31(4):717-723.
    OpenUrlCrossRefPubMedWeb of Science
  108. 108.↵
    1. Livermore N,
    2. Sharpe L,
    3. McKenzie D
    . Prevention of panic attacks and panic disorder in COPD. Eur Respir J 2010;35(3):557-563.
    OpenUrlAbstract/FREE Full Text
  109. 109.↵
    1. de Godoy DV,
    2. de Godoy RF
    . A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003;84(8):1154-1157.
    OpenUrlCrossRefPubMedWeb of Science
  110. 110.↵
    1. Hynninen MJ,
    2. Bjerke N,
    3. Pallesen S,
    4. Bakke PS,
    5. Nordhus IH
    . A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med 2010;104(7):986-994.
    OpenUrlCrossRefPubMed
  111. 111.↵
    1. Vickers A,
    2. Zollman C
    . ABC of complementary medicine. Hypnosis and relaxation therapies. BMJ 1999;319(7221):1346-1349.
    OpenUrlFREE Full Text
  112. 112.↵
    1. Devine EC,
    2. Pearcy J
    . Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ Couns 1996;29(2):167-178.
    OpenUrlCrossRefPubMedWeb of Science
  113. 113.↵
    1. Lolak S,
    2. Connors GL,
    3. Sheridan MJ,
    4. Wise TN
    . Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom 2008;77(2):119-125.
    OpenUrlCrossRefPubMed
  114. 114.↵
    1. Donesky-Cuenco D,
    2. Nguyen HQ,
    3. Paul S,
    4. Carrieri-Kohlman V
    . Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med 2009;15(3):225-234.
    OpenUrlCrossRefPubMed
  115. 115.↵
    1. Jonker AAGC,
    2. Comijs HC,
    3. Knipscheer KCM,
    4. Deeg DJH
    . Promotion of self-management in vulnerable older people: a narrative literature review of outcomes of the Chronic Disease Self-Management Program (CDSMP). Eur J Ageing 2009;6(4):303-314.
    OpenUrlCrossRefPubMedWeb of Science
  116. 116.↵
    1. Bourbeau J,
    2. Julien M,
    3. Maltais F,
    4. Rouleau M,
    5. Beaupré A,
    6. Bégin R,
    7. et al
    ; Chronic Obstructive Pulmonary Disease Axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163(5):585-591.
    OpenUrlCrossRefPubMedWeb of Science
  117. 117.↵
    1. Effing T,
    2. Monninkhof EM,
    3. van der Valk PDLPM,
    4. van der Palen J,
    5. van Herwaarden CLA,
    6. Partidge MR,
    7. et al
    . Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007(4):CD002990.
  118. 118.↵
    1. Watson M,
    2. White C,
    3. Davolls S,
    4. Mohammed A,
    5. Lynch A,
    6. Mohammed K
    . Problem-focussed interactive telephone therapy for cancer patients: a phase II feasibility trial. Psychooncology 2013;22(7):1485-1491.
    OpenUrl
  119. 119.↵
    1. Stiles-Shields C,
    2. Kwasny MJ,
    3. Cai X,
    4. Mohr DC
    . Therapeutic alliance in face-to-face and telephone-administered cognitive behavioral therapy. J Consult Clin Psychol 2014;82(2):349-354.
    OpenUrl
  120. 120.↵
    1. Veazey C,
    2. Cook KF,
    3. Stanley M,
    4. Lai EC,
    5. Kunik ME
    . Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings 2009;16(3):243-253.
    OpenUrlCrossRefPubMed
  121. 121.↵
    1. Huhn M,
    2. Tardy M,
    3. Spineli LM,
    4. Kissling W,
    5. Förstl H,
    6. Pitschel-Walz G,
    7. et al
    . Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014;71(6):706-715.
    OpenUrl
  122. 122.↵
    1. Sharafkhaneh A,
    2. Yohannes A,
    3. Hanania N,
    4. Kunik M
    1. Majid H,
    2. Nadeem T
    . Anxiety and depression in COPD patients. In: Sharafkhaneh A, Yohannes A, Hanania N, Kunik M, editors. Depression and anxiety in patients with chronic respiratory diseases. New York: Springer; 2017; 4:57-72.
    OpenUrl
  123. 123.↵
    1. Usmani ZA,
    2. Carson KV,
    3. Cheng JN,
    4. Esterman AJ,
    5. Smith BJ
    . Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011(11):CD008483.
    OpenUrlPubMed
  124. 124.↵
    1. He Y,
    2. Zheng Y,
    3. Xu C,
    4. Yang H,
    5. Wang Z,
    6. Zhou L,
    7. et al
    . Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J 2016;10(3):318-325.
    OpenUrl
  125. 125.↵
    1. Eiser N,
    2. Harte R,
    3. Spiros K,
    4. Phillips C,
    5. Isaac MT
    . Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005;2(2):233-241.
    OpenUrlCrossRefPubMed
  126. 126.↵
    1. Lacasse Y,
    2. Beaudoin L,
    3. Rousseau L,
    4. Maltais F
    . Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004;61(3):140-147.
    OpenUrlPubMed
  127. 127.↵
    1. Yohannes AM,
    2. Connolly MJ,
    3. Baldwin RC
    . A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001;16(5):451-454.
    OpenUrlCrossRefPubMedWeb of Science
  128. 128.↵
    1. Yohannes AM,
    2. Connolly MJ
    . Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med 2011;5(6):727-729.
    OpenUrlCrossRefPubMed
  129. 129.↵
    1. Halvorsen T,
    2. Martinussen PE
    . Benzodiazepine use in COPD: empirical evidence from Norway. Int J Chron Obstruct Pulmon Dis 2015;10:1695-1702.
    OpenUrl
  130. 130.↵
    1. Wang M-T,
    2. Tsai C-L,
    3. Lin CW,
    4. Yeh C-B,
    5. Wang Y-H,
    6. Lin H-L
    . Association between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary disease. JAMA Psychiatry 2017;74(3):252-260.
    OpenUrl
  131. 131.↵
    1. Smoller JW,
    2. Pollack MH,
    3. Otto MW,
    4. Rosenbaum JF,
    5. Kradin RL
    . Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 1996;154(1):6-17.
    OpenUrlCrossRefPubMedWeb of Science
  132. 132.↵
    1. Kroll DS,
    2. Nieva HR,
    3. Barsky AJ,
    4. Linder JA
    . Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. J Gen Intern Med 2016;31(9):1027-1034.
    OpenUrl
  133. 133.↵
    1. Celli BR,
    2. MacNee W
    ; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
    OpenUrlFREE Full Text
  134. 134.↵
    1. Stage KB,
    2. Middelboe T,
    3. Stage TB,
    4. Sørensen CH
    . Depression in COPD–management and quality of life considerations. Int J Chron Obstruct Pulmon Dis 2006;1(3):315-320.
    OpenUrlPubMed
  135. 135.↵
    1. Rayner L,
    2. Price A,
    3. Evans A,
    4. Valsraj K,
    5. Higginson IJ,
    6. Hotopf M
    . Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010(3):CD007503.
  136. 136.↵
    1. Ejiofor S,
    2. Turner AM
    . Pharmacotherapies for COPD. Clin Med Insights Circ Respir Pulm Med 2013;7:17-34.
    OpenUrl
  137. 137.↵
    1. Ries AL,
    2. Bauldoff GS,
    3. Carlin BW,
    4. Casaburi R,
    5. Emery CF,
    6. Mahler DA,
    7. et al
    . Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131(5 Suppl):4S-42S.
    OpenUrlCrossRefPubMedWeb of Science
  138. 138.↵
    1. Ries AL
    . Pulmonary rehabilitation: summary of an evidence-based guideline. Respir Care 2008;53(9):1203-1207.
    OpenUrlAbstract/FREE Full Text
  139. 139.↵
    1. Garvey C,
    2. Bayles MP,
    3. Hamm LF,
    4. Hill K,
    5. Holland A,
    6. Limberg TM,
    7. Spruit MA
    . Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev 2016;36(2):75-83.
    OpenUrlCrossRefPubMed
  140. 140.↵
    1. Bhandari NJ,
    2. Jain T,
    3. Marolda C,
    4. ZuWallack RL
    . Comprehensive pulmonary rehabilitation results in clinically meaningful improvements in anxiety and depression in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2013;33(2):123-127.
    OpenUrl
  141. 141.↵
    1. Janssen DJA,
    2. Spruit MA,
    3. Leue C,
    4. Gijsen C,
    5. Hameleers H,
    6. Schols JMGA,
    7. Wouters EFM
    ; Ciro network. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010;7(3):147-157.
    OpenUrlCrossRefPubMed
  142. 142.↵
    1. Garrod R,
    2. Marshall J,
    3. Barley E,
    4. Jones PW
    . Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 2006;27(4):788-794.
    OpenUrlAbstract/FREE Full Text
  143. 143.↵
    1. von Leupoldt A,
    2. Taube K,
    3. Lehmann K,
    4. Fritzsche A,
    5. Magnussen H
    . The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011;140(3):730-736.
    OpenUrlCrossRefPubMedWeb of Science
  144. 144.↵
    1. Harris D,
    2. Hayter M,
    3. Allender S
    . Improving the uptake of pulmonary rehabilitation in patients with COPD: qualitative study of experiences and attitudes. Br J Gen Pract 2008;58(555):703-710.
    OpenUrlAbstract/FREE Full Text
  145. 145.↵
    1. Yohannes AM,
    2. Casaburi R,
    3. Dryden S,
    4. Hanania NA
    . Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med 2022;193:106742.
    OpenUrl
  146. 146.↵
    1. Pirraglia PA,
    2. Casserly B,
    3. Velasco R,
    4. Borgia ML,
    5. Nici L
    . Association of change in depression and anxiety symptoms with functional outcomes in pulmonary rehabilitation patients. J Psychosom Res 2011;71(1):45-49.
    OpenUrlCrossRefPubMed
  147. 147.↵
    1. Griffiths TL,
    2. Burr ML,
    3. Campbell IA,
    4. Lewis-Jenkins V,
    5. Mullins J,
    6. Shiels K,
    7. et al
    . Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355(9201):362-368.
    OpenUrlCrossRefPubMedWeb of Science
  148. 148.↵
    1. Paz-Díaz H,
    2. Montes de Oca M,
    3. López JM,
    4. Celli BR
    . Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007;86(1):30-36.
    OpenUrlCrossRefPubMedWeb of Science
  149. 149.↵
    1. Yohannes AM,
    2. Dryden S,
    3. Casaburi R,
    4. Hanania NA
    . Long-term benefits of pulmonary rehabilitation in patients with COPD: a 2-year follow-up study. Chest 2021;159(3):967-974.
    OpenUrl
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords